Jefferson Biologist Coaxing Human Embryonic Stem Cells To Make Dopamine With Simpler, Faster Method
For all of the promise embryonic stem cells hold for therapies for neurodegenerative diseases such as Parkinson's disease, they are notoriously difficult to use. One problem is in coaxing them into becoming brain cells that make dopamine, which is in short supply in the brains of individuals with Parkinson's. Such cells might be used for transplantation in these patients, but current methods involve extremely complex growth media and potentially contaminating animal products.
Related News Stories
Jefferson Scientists Find New Way To Convert Adult Human Stem Cells To Dopamine Neurons (October 26, 2004) -- Researchers at Jefferson Medical College have found a new way to coax bone marrow stem cells into becoming dopamine-producing neurons. If the method proves reliable, the work may ultimately lead to ... > full story
Jefferson Scientists Show Neural Stem Cells Can Become Dopamine-Making Brain Cells In Laboratory (November 6, 2002) -- Biologists at Jefferson Medical College have shown for the first time in the laboratory that they can convert some human neural stem cells to brain cells that can produce dopamine, the brain chemical ... > full story
Jefferson Researchers Have Early Evidence Of Bone Marrow Stem Cells Able To Become Brain Cells (November 12, 2001) -- Using a potion of growth factors and other nutrients, scientists at Jefferson Medical College have shown in the laboratory they are able to convert adult human bone marrow stem cells into adult brain ... > full story
Melatonin could be a key to someday understanding how to treat Parkinson's disease. Scientists at Jefferson Medical College have shown in the laboratory and in test animals that melatonin is ...
Now, developmental biologist Lorraine Iacovitti, Ph.D., associate director of the Farber Institute for Neurosciences at Thomas Jefferson University in Philadelphia, and her co-workers have devised a quicker, simpler method.
Dr. Iacovitti, who is also professor of neurology at Jefferson Medical College of Thomas Jefferson University, and her co-workers devised a technique using only a few additives, "all chemically defined and of human origin" to get embryonic stem cells to become dopamine-producing in the laboratory dish in only three weeks, compared to the five-to-eight week period it usually takes. She reports her group's results November 13, 2005 at the annual meeting of the Society for Neuroscience in Washington, D.C.
According to Dr. Iacovitti, researchers have been using blood serum, serum replacement products and cell conditioned media, all of which contain "undefined proprietary components and growth substances of animal origin." Such animal-derived substances can cause an immune reaction and result in the rejection of dopamine-producing cells transplanted into a patient's bdrain.
"The goal is to get the best source of dopamine neurons and the simplest reagent and media in which to grow cells," she says. "Everyone should be trying to use human cells that have seen only human reagents."
In the work, she and her co-workers used various cell markers to track changes in stem cell development, chronicling each of five steps to become a dopamine cell. They eventually were able to get the cells to form dopamine neurons, she says, but they could not harvest the cells from culture for transplantation. Dr. Iacovitti decided to stop the process and revert back to an earlier developmental stage.
Shortening the differentiation process is important, she notes. The longer cells are grown and allowed to mature in culture before transplant, the less able they are to survive harvest for transplant. "We transplant cells at two weeks in stage four of development and not after three weeks and stage five for this reason," she says. "The brain can finish the process of differentiating cells into dopamine neurons.
"
----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn
